MCK

#144
McKesson Corporation
872.0000 USD
+1.19%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
867.9700
872.0000
Intervallo Annuale
789.9600
999.0000
Variazione giornaliera
+1.19%
Variazione Mensile
-8.00%
Variazione di 6 mesi
+8.66%
Variazione Annuale
+8.66%
Chiusura Precedente
861.7600
Apertura
868.3600
Bid
Ask
Minimo
867.9700
High
872.0000
Volume
50
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 106.8091 B
  • Employee 51 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
23.67
Rapporto prezzo/fatturato
0.26
Dividendi per azione
0.82
Rendimento da dividendi %
0.62

McKesson Corporation

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

Notizie